Incyte
INCY
#1182
Rank
โ‚ฌ15.95 B
Marketcap
81,26ย โ‚ฌ
Share price
0.01%
Change (1 day)
18.08%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2025 (TTM): โ‚ฌ1.40 Billion

According to Incyte's latest financial reports the company's current earnings are โ‚ฌ4.81 Billion. In 2024 the company made an earning of โ‚ฌ0.27 Billion a decrease over its 2023 earnings that were of โ‚ฌ0.71 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ1.40 B418.73%
2024 โ‚ฌ0.27 B-62.04%
2023 โ‚ฌ0.71 B57.66%
2022 โ‚ฌ0.45 B-7.24%
2021 โ‚ฌ0.48 B-345.65%
2020 -โ‚ฌ0.2 Billion-147.7%
2019 โ‚ฌ0.41 B322.02%
2018 โ‚ฌ98.48 M-136.94%
2017 -โ‚ฌ0.27 Billion-390.76%
2016 โ‚ฌ91.7 M1322%
2015 โ‚ฌ6.44 M-115.56%
2014 -โ‚ฌ41.45 Million-41.4%
2013 -โ‚ฌ70.74 Million87.67%
2012 -โ‚ฌ37.7 Million-74.9%
2011 -โ‚ฌ0.16 Billion843.59%
2010 -โ‚ฌ15.92 Million-88.68%
2009 -โ‚ฌ0.15 Billion1.37%
2008 -โ‚ฌ0.14 Billion86.16%
2007 -โ‚ฌ74.5 Million17.64%
2006 -โ‚ฌ63.33 Million-28.62%
2005 -โ‚ฌ88.72 Million-36.1%
2004 -โ‚ฌ0.14 Billion-2.03%
2003 -โ‚ฌ0.15 Billion22.26%
2002 -โ‚ฌ0.12 Billion-27.39%
2001 -โ‚ฌ0.16 Billion198.72%
2000 -โ‚ฌ53.44 Million132.2%
1999 -โ‚ฌ23.02 Million-556.86%
1998 โ‚ฌ5.03 M-37.23%
1997 โ‚ฌ8.02 M-259.32%
1996 -โ‚ฌ5.04 Million-45.87%
1995 -โ‚ฌ9.31 Million-9.17%
1994 -โ‚ฌ10.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚ฌ7.03 B 419.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ57.02 M-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ19.21 B 1,316.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.11 B 646.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚ฌ39.21 Million-102.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚ฌ47.43 Million-103.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ14.01 B 933.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
-โ‚ฌ24.8 Million-101.83%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚ฌ59.12 Million-104.36%๐Ÿ‡บ๐Ÿ‡ธ USA